Purchases and Sales Made in Q4 2023 in Larimar Therapeutics, Inc. (LRMR)
This table provides information about the institutional ownership of Larimar Therapeutics, Inc. (LRMR) during Q4 2023. The information is specifically focused on institutions that hold shares of Larimar Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-49.9K- 31.34% |
$117K - $235K
|
109K
$362K
|
|
|
Feb 14, 2024
Q4 2023
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-58.6K- 15.48% |
$138K - $276K
|
320K
$1.06M
|
|
|
Feb 16, 2024
Q4 2023
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-64K- 71.72% |
$150K - $301K
|
25.2K
$83.5K
|
|
|
Feb 14, 2024
Q4 2023
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-80K- 11.72% |
$188K - $377K
|
603K
$2M
|
|
|
Feb 14, 2024
Q4 2023
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-89.4K- 3.08% |
$210K - $421K
|
2.81M
$9.3M
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-148K- 71.7% |
$349K - $699K
|
58.6K
$194K
|
|
|
Feb 14, 2024
Q4 2023
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-225K- 26.52% |
$529K - $1.06M
|
624K
$2.06M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-297K- 30.31% |
$698K - $1.4M
|
682K
$2.26M
|